Jenny Rooke

Managing Director · Genoa Ventures · San Francisco, United States

Decision makerActive

Verified, deliverable email

Unlock Jenny and the rest of Genoa Ventures

One payment, no subscription - every verified contact at Genoa Ventures drops into your wallet.

Managing Director at Genoa Ventures

Stages: Seed, Series A
Sectors: Health tech
Cheque size: €230k–€9.2M
Location: San Francisco, United States
Freshness: Verified today
Fund size: $26.5M

Notable investments

Tropic BiosciencesSeries C · $110M · 2026
BrightSpecSeries C · $18M · 2022
Bond Pet FoodsSeries A · $18M · 2022
MeiogenixSeries A · $12M · 2021
InterVennSeries C · $200M · 2021
IonpathSeries B · $18M · 2020
IntabioSeries B · $18M · 2020
NanoCellect BiomedicalSeries B · $10M · 2017

Frequently co-invests with

Adam D'AugelliTrue VenturesAlexis Yongmei JiIllumina VenturesDavid MichaelAnzu PartnersJaffray WoodriffKris KemenyTekfen VenturesMichael RubinNorthpond VenturesMike DybbsSamsara BioCapitalPaul ConleyPaladin Capital GroupSunil DhaliwalAmplify PartnersTaz Patel

Background

Investor, Board ObserverFellow2023–present
Investor, DirectorBrightSpec, Inc.2022–present
Investor, Board ObserverGeneral Inception2022–present
InvestorRedux Bio2021–present
Investor, DirectorStemson Therapeutics2021–present
Investor, DirectorMeiogenix2021–present
Investor, DirectorAqtual, Inc.2021–present
InvestorTropic2020–present
Member Board of TrusteesThe Jackson Laboratory2019–present
Investor, Chair of the BoardInterVenn Biosciences2018–present
AdvisorBill & Melinda Gates Foundation2016–present
InvestorIonpath Inc.2015–present
Managing DirectorGenoa Ventures2012–present
Managing DirectorGenoa Ventures Part-time
Investor, Board ObserverIonpath Inc.
Venture PartnerF-Prime Capital
AdvisorGATES FOUNDATION
InvestorIonpath
InvestorZymergen
Investor, DirectorNewCo
Venture PartnerF-Prime
Board of DirectorsNewCo
Investor, AdvisorBio-Techne
Senior Program Officer, Global Health DiscoveryGATES FOUNDATION
Associate, Kauffman FellowNewCo
VP Corporate DevelopmentUS Genomics
VP Research & Development / CSOUS Genomics
Director, Business Development / Director of Collaborative R&DUS Genomics
Engagement ManagerMcKinsey & Company
Investor, DirectorUniversity of Washington Applied Physics Laboratory
Board of DirectorsUniversity of Washington Applied Physics Laboratory
Associate, Kauffman FellowUniversity of Washington Applied Physics Laboratory
Investor, DirectorXtripe Angels
Investor, DirectorFidelity Biosciences
InvestorZymergen, Inc.2014–2022
Investor, DirectorIntabio2017–2020
AdvisorCaribou Biosciences2016–2020
Board MemberKauffman Fellows2009–2020
Venture PartnerF-Prime Capital Partners2013–2017
Venture PartnerAnterra Capital2016–2017
Board of DirectorsCytek Biosciences2015–2016
Board of DirectorsCaribou Biosciences2014–2016
Investor, AdvisorZephyrus Biosciences2014–2016
Senior Program Officer, Global Health DiscoveryBill & Melinda Gates Foundation2008–2012
Associate, Kauffman FellowFidelity Biosciences2006–2008
VP Corporate DevelopmentU.S. Genomics2005–2006
VP Research & Development / CSOU.S. Genomics2004–2005
Director, Business Development / Director of Collaborative R&DU.S. Genomics2001–2004
Engagement ManagerMcKinsey & Co1998–2001